STRAUMANN HOLDING AG-REG

Straumann Holding raises 2026 profit outlook, boosting shares. 140‑170 bp EBIT margin upgrade via cost cuts, better geography and lower tariffs. Expect sustained gains.

Explore how Swiss equity movements reveal shifts in pharma and medical‑device pricing, reimbursement models, and operational resilience—key insights for stakeholders navigating healthcare economics.